StockData
Entrada Therapeutics, Inc. logo

Entrada Therapeutics, Inc. (TRDA) community

TRDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$5.09−0.08 (-1.55%)

Close on Nov 13, 2026Market cap $198.19MP/E –Yield –

Community

Notes and questions about Entrada Therapeutics from other investors

No posts about TRDA yet

Discussion is coming to every stock. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

See a number that looks wrong?